2m 2m 2m 2m 2m 2m 2m
PROKIDNEY-A (PROK)
NASDAQ
$1.54-$0.005 (-0.32%)
Price as of Aug 03, 2026 4:01 AM EDT- $316.0MMarket Cap
- -45.39%1-Year Change
- BiotechnologyIndustry
PROKIDNEY-A (PROK)
$1.54-$0.005 (-0.32%)
PROK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.54 | ||
Change | -$0.04 (-2.53%) | ||
Open | $1.56 | ||
High | $1.58 | ||
Low | $1.50 | ||
Previous Close | $1.58 | ||
Volume | 809,088 | ||
30-Day Average Volume | 1,110,979 | ||
1-Week Change | 2.67% | ||
1-Month Change | -24.51% | ||
1-Year Change | -45.39% | ||
3-Year Change | -87.99% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 205.2M | ||
Total Assets | $292.8M | ||
Market Cap | $316.0M | ||
Enterprise Value | $214.1M | ||
Period: QTR TTM FY | |||
Revenue | $226,000.00 | ||
Net Income | -$20.0M | ||
Free Cash Flow | -$45.5M | ||
EBIT | -$20.0M | ||
EBITDA | -$18.4M | ||
Net Working Capital | $209.0M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 947 | ||
P/B | -0 | ||
P/E | -11 | ||
PEG | 4 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue